Aytu Biopharma Inc expected to post a loss of 28 cents a share - Earnings Preview

Aytu Biopharma

03/02/2025 12:18

* Aytu Biopharma Inc  AYTU.OQ   AYTU.O  is expected to show
a fall
in quarterly revenue when it reports  results on February 5
(estimated) for the period ending December 31 2024
    * The Denver Colorado-based  company is expected to report a
32.2% decrease in revenue to $15.554 million from $22.93 million
a year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for Aytu Biopharma Inc is
for a
loss of 28 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aytu
Biopharma
Inc is $8.00​, above​ its last closing price of $1.67. ​​​

This summary was machine generated February 3 at 12:18 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)